SCHEMBL8149166

SCHEMBL8149166

Bc1nc(Br)sc1C(=O)OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.45
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPSR1 Q6W5P4 2/20 0.40
HPGD P15428 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 6/20 0.39
KDM4E B2RXH2 2/20 0.39
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
PPARG P37231 1/20 0.37
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12670519 0.81 TRPM8 (0.45) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL622999 0.80 HSD17B10 (0.47) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL8146643 0.79 KDM4E (0.48) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL560326 0.78 RAB9A (0.51) KMT2AMAPTTSHRHSD17B10NPSR1
SCHEMBL12677142 0.77 L3MBTL1 (0.42) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL2825372 0.74 KMT2A (0.47) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL2624099 0.74 KMT2A (0.41) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL8153820 0.74 RAF1 (0.42) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL2632700 0.73 NPSR1 (0.50) TRPM8KMT2AMAPTTSHRHSD17B10
SCHEMBL13545562 0.73 HPGD (0.46) MAPTHSD17B10NPSR1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222328-A1 2-CYCLOPROPYL-THIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD. (CH) 2010-09-02 US disclosed
US-20100222328-A1 2-CYCLOPROPYL-THIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD. (CH) 2010-09-02 US disclosed
WO-2008139416-A1 2-CYCLOPROPYL-THIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222328-A1 2-CYCLOPROPYL-THIAZOLE DERIVATIVES HCRTR2, HCRTR1, NPY2R TRPM8 323/4885KMT2A 2162/4885MAPT 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.